Filtered By:
Source: The Lancet
This page shows you your search results in order of relevance. This is page number 10.
Order by Relevance | Date
Total 200 results found since Jan 2013.
Stroke in ICD-11: the end of a long exile
Publication date: 17–23 June 2017 Source:The Lancet, Volume 389, Issue 10087 Author(s): Raad Shakir, Bo Norrving
Source: The Lancet - June 16, 2017 Category: General Medicine Source Type: research
Chagas disease
Publication date: Available online 30 June 2017 Source:The Lancet Author(s): José A Pérez-Molina, Israel Molina Chagas disease is an anthropozoonosis from the American continent that has spread from its original boundaries through migration. It is caused by the protozoan Trypanosoma cruzi, which was identified in the first decade of the 20th century. Once acute infection resolves, patients can develop chronic disease, which in up to 30–40% of cases is characterised by cardiomyopathy, arrhythmias, megaviscera, and, more rarely, polyneuropathy and stroke. Even after more than a century, many challenges remain unresolved...
Source: The Lancet - July 1, 2017 Category: General Medicine Source Type: research
Unmet challenges for rehabilitation after stroke in China
Publication date: 8–14 July 2017 Source:The Lancet, Volume 390, Issue 10090 Author(s): Tetsuya Asakawa, Liang Zong, Liang Wang, Ying Xia, Hiroki Namba
Source: The Lancet - July 7, 2017 Category: General Medicine Source Type: research
Intensive speech and language therapy after stroke
Publication date: 15–21 July 2017 Source:The Lancet, Volume 390, Issue 10091 Author(s): Ryo Sakamoto, Asaka Higuchi, Kenji Tsuda, Tetsuya Tanimoto, Masahiro Kami
Source: The Lancet - July 15, 2017 Category: General Medicine Source Type: research
Intensive speech and language therapy after stroke – Authors' reply
Publication date: 15–21 July 2017 Source:The Lancet, Volume 390, Issue 10091 Author(s): Caterina Breitenstein, Peter Martus, Klaus Willmes, Wolfram Ziegler, Annette Baumgaertner
Source: The Lancet - July 15, 2017 Category: General Medicine Source Type: research
A global coalition for the fight against heart disease and stroke
Publication date: Available online 16 October 2017 Source:The Lancet Author(s): David Wood, Jean-Luc Eiselé
Source: The Lancet - October 17, 2017 Category: General Medicine Source Type: research
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Publication date: Available online 10 November 2017 Source:The Lancet Author(s): Stuart J Connolly, John W Eikelboom, Jackie Bosch, Gilles Dagenais, Leanne Dyal, Fernando Lanas, Kaj Metsarinne, Martin O'Donnell, Anthony L Dans, Jong-Won Ha, Alexandr N Parkhomenko, Alvaro A Avezum, Eva Lonn, Liu Lisheng, Christian Torp-Pedersen, Petr Widimsky, Aldo P Maggioni, Camilo Felix, Katalin Keltai, Masatsugu Hori, Khalid Yusoff, Tomasz J Guzik, Deepak L Bhatt, Kelley R H Branch, Nancy Cook Bruns, Scott D Berkowitz, Sonia S Anand, John D Varigos, Keith A A Fox, Salim Yusuf Background Coronary artery disease is a major cause of morbi...
Source: The Lancet - November 11, 2017 Category: General Medicine Source Type: research
Learning from TARDIS: time for more focused trials in stroke prevention
Publication date: Available online 20 December 2017 Source:The Lancet Author(s): Pierre Amarenco
Source: The Lancet - December 21, 2017 Category: General Medicine Source Type: research
Stroke —acting FAST at all ages
Publication date: 10–16 February 2018 Source:The Lancet, Volume 391, Issue 10120 Author(s): The Lancet
Source: The Lancet - February 9, 2018 Category: General Medicine Source Type: research
Investing in non-communicable diseases: an estimation of the return on investment for prevention and treatment services
Publication date: Available online 5 April 2018 Source:The Lancet Author(s): Melanie Y Bertram, Kim Sweeny, Jeremy A Lauer, Daniel Chisholm, Peter Sheehan, Bruce Rasmussen, Senendra Raj Upreti, Lonim Prasai Dixit, Kenneth George, Samuel Deane The global burden of non-communicable diseases (NCDs) is growing, and there is an urgent need to estimate the costs and benefits of an investment strategy to prevent and control NCDs. Results from an investment-case analysis can provide important new evidence to inform decision making by governments and donors. We propose a methodology for calculating the economic benefits of investi...
Source: The Lancet - April 7, 2018 Category: General Medicine Source Type: research
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
Publication date: 14–20 April 2018 Source:The Lancet, Volume 391, Issue 10129 Author(s): Angela M Wood, Stephen Kaptoge, Adam S Butterworth, Peter Willeit, Samantha Warnakula, Thomas Bolton, Ellie Paige, Dirk S Paul, Michael Sweeting, Stephen Burgess, Steven Bell, William Astle, David Stevens, Albert Koulman, Randi M Selmer, W M Monique Verschuren, Shinichi Sato, Inger Njølstad, Mark Woodward, Veikko Salomaa, Børge G Nordestgaard, Bu B Yeap, Astrid Fletcher, Olle Melander, Lewis H Kuller, Beverley Balkau, Michael Marmot, Wolfgang Koenig, Edoardo Casiglia, Cyrus Cooper, Volker Arndt, Oscar H Franco, Patrik Wennberg, Jo...
Source: The Lancet - April 13, 2018 Category: General Medicine Source Type: research
Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis
This study is registered with PROSPERO, number CRD42017065697. Findings 25 randomised controlled trials enrolled 16 037 patients with sepsis, critical illness, stroke, trauma, myocardial infarction, or cardiac arrest, and patients who had emergency surgery. Compared with a conservative oxygen strategy, a liberal oxygen strategy (median baseline saturation of peripheral oxygen [SpO2] across trials, 96% [range 94–99%, IQR 96–98]) increased mortality in-hospital (relative risk [RR] 1·21, 95% CI 1·03–1·43, I 2=0%, high quality), at 30 days (RR 1·14, 95% CI 1·01–1·29, I 2=0%, high quality), and at longest follow...
Source: The Lancet - April 28, 2018 Category: General Medicine Source Type: research
Stroke units around the world: the success story continues
Publication date: 19–25 May 2018 Source:The Lancet, Volume 391, Issue 10134 Author(s): Michael Brainin
Source: The Lancet - May 18, 2018 Category: General Medicine Source Type: research
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
Publication date: 9–15 June 2018 Source:The Lancet, Volume 391, Issue 10137 Author(s): P J Devereaux, Emmanuelle Duceppe, Gordon Guyatt, Vikas Tandon, Reitze Rodseth, Bruce M Biccard, Denis Xavier, Wojciech Szczeklik, Christian S Meyhoff, Jessica Vincent, Maria Grazia Franzosi, Sadeesh K Srinathan, Jason Erb, Patrick Magloire, John Neary, Mangala Rao, Prashant V Rahate, Navneet K Chaudhry, Bongani Mayosi, Miriam de Nadal, Pilar Paniagua Iglesias, Otavio Berwanger, Juan Carlos Villar, Fernando Botto, John W Eikelboom, Daniel I Sessler, Clive Kearon, Shirley Pettit, Mukul Sharma, Stuart J Connolly, Shrikant I Bangdiwala, ...
Source: The Lancet - June 8, 2018 Category: General Medicine Source Type: research
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
Publication date: Available online 17 July 2018Source: The LancetAuthor(s): Peter M Rothwell, Nancy R Cook, J Michael Gaziano, Jacqueline F Price, Jill F F Belch, Maria Carla Roncaglioni, Takeshi Morimoto, Ziyah MehtaSummaryBackgroundA one-dose-fits-all approach to use of aspirin has yielded only modest benefits in long-term prevention of cardiovascular events, possibly due to underdosing in patients of large body size and excess dosing in patients of small body size, which might also affect other outcomes.MethodsUsing individual patient data, we analysed the modifying effects of bodyweight (10 kg bands) and height (10 cm ...
Source: The Lancet - July 18, 2018 Category: General Medicine Source Type: research
